ornithylaspartate has been researched along with Liver Failure, Acute in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jalan, R; Lee, WM | 1 |
| Acharya, SK; Bhatia, V; Khanal, S; Panda, SK; Sreenivas, V | 1 |
| Carmona Soria, I; García Montes, JM; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Quero Guillén, JC | 1 |
| Butterworth, RF | 1 |
| Hein, G; Katenkamp, K; Linde, B; Oelzner, P; Wolf, G | 1 |
| Butterworth, RF; Kircheis, G; Michalak, A; Quack, G; Rao, KV; Rose, C | 1 |
1 review(s) available for ornithylaspartate and Liver Failure, Acute
| Article | Year |
|---|---|
Brain edema in acute liver failure.
Topics: Ammonia; Animals; Astrocytes; Brain Edema; Dipeptides; Humans; Hypothermia, Induced; Intracranial Pressure; Liver Failure, Acute | 2003 |
1 trial(s) available for ornithylaspartate and Liver Failure, Acute
| Article | Year |
|---|---|
Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperammonemia; Kaplan-Meier Estimate; Liver Failure, Acute; Male; Probability; Prospective Studies; Reference Values; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2009 |
4 other study(ies) available for ornithylaspartate and Liver Failure, Acute
| Article | Year |
|---|---|
Treatment of hyperammonemia in liver failure: a tale of two enzymes.
Topics: Dipeptides; Double-Blind Method; Female; Humans; Hyperammonemia; Liver Failure, Acute; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate; Treatment Outcome | 2009 |
Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bromocriptine; Dipeptides; Dopamine Agonists; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure, Acute; Liver Transplantation; Neomycin; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Prognosis; Sodium Benzoate; Terminology as Topic; Time Factors; Zinc | 2003 |
[Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain].
Topics: Administration, Oral; Adult; Arthralgia; Biopsy; Diagnosis, Differential; Dipeptides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Hepatomegaly; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukocytosis; Liver; Liver Failure, Acute; Liver Function Tests; Methylprednisolone; Prednisolone; Splenomegaly; Still's Disease, Adult-Onset; Ursodeoxycholic Acid | 2007 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sprague-Dawley | 1999 |